CHARACTERIZATION OF THE DEVELOPMENTAL TOXICITY OF DI-N-BUTYL PHTHALATE IN RATS
Citation
M. Ema et al., CHARACTERIZATION OF THE DEVELOPMENTAL TOXICITY OF DI-N-BUTYL PHTHALATE IN RATS, Toxicology, 86(3), 1994, pp. 163-174
Categorie Soggetti
Toxicology,"Pharmacology & Pharmacy
SICI code
0300-483X(1994)86:3<163:COTDTO>2.0.ZU;2-7
Abstract
The objective of this study was to determine the characterization of t
he developmental toxicity of di-n-butyl phthalate (DBP) in rats. Pregn
ant rats were given DBP by gastric intubation at a dose of 0.75, 1.0 o
r 1.5 g/kg on days 7-9, 10-12 or 13-15 of pregnancy. Postimplantation
loss was 100% for each period of dosing at 1.5 g/kg. A significant inc
rease in the postimplantation loss was found in dams given DBP at dose
s of 0.75 and 1.0 g/kg regardless of the days of treatment. No evidenc
e of teratogenicity was detected when DBP was given on days 10-12. Tre
atment on days 7-9 with DBP at doses of 0.75 and 1.0 g/kg caused a sig
nificant increase in the number of skeletal malformations such as defo
rmity of the vertebral column in the cervical and thoracic regions and
of the ribs, but neither external nor internal malformations. Treatme
nt with DBP on days 13-15 at doses of 0.75 and 1.0 g/kg resulted in a
significant increase in the incidence of fetuses with external and ske
letal malformations such as cleft palate and fusion of the sternebrae.
The frequency of malformations increased as the dose of DBP was incre
ased. The highest incidence of malformed fetuses occurred after treatm
ent with DBP on days 13-15. It could be concluded that susceptibility
to the teratogenicity of DBP varies with the developmental stage at th
e time of administration.